Oncologix Tech, Inc. (OTCPK:OCLG) is seeking acquisitions. Wayne Erwin, Chief Executive Officer of Oncologix said, "Our continued debt reduction strategy benefits the company in multiple ways including decreasing the downward pressure of the stock, reducing corporate debt, and an improving our balance sheet. It is our belief that this plan, together with strategic acquisitions, will greatly increase our shareholder value."
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+191.09% | 7.13B | |
+2.10% | 982M | |
+41.91% | 872M | |
+26.45% | 820M | |
+1.77% | 664M | |
+5.92% | 648M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- OCLG Stock
- News Oncologix Tech, Inc.
- Oncologix Tech Mulls Acquisitions